NCT05909696View on ClinicalTrials.gov

Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 31, 2023

Conditions
SuccinylcholineMyofibrillation
Interventions
DRUG

rocuronium

Advanced intravenous injection of rocuronium before the succinylcholine injection

Trial Locations (1)

Unknown

the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou

All Listed Sponsors
lead

Yangzhou University

OTHER